Introduction
============

Among toxin-related toxic phenomena, diarrhetic shellfish poisoning (DSP) represents a serious threat to both public health and the shellfish industry. Following the first episodes of DSP, the polyether lipophilic compounds okadaic acid (OA) and its methyl derivative, dinophysistoxin (DTX-1) were identified in toxic shellfish \[[@b1-md504168],[@b2-md504168]\]. Congeners of these toxins, such as the OA isomer (DTX-2) \[[@b3-md504168]\] and a number of ester derivatives of OA, DTX-1 and DTX-2 were subsequently identified in shellfish \[[@b4-md504168]--[@b6-md504168]\]. Other toxins usually coexisting with OA analogues, but differing from them in terms of their chemical structures, include the pectenotoxins (PTXs) \[[@b7-md504168]\], the yessotoxins (YTXs) \[[@b8-md504168],[@b9-md504168]\] and azaspiracids (AZAs) \[[@b10-md504168],[@b11-md504168]\]. Other marine toxins were also identified - both spirolides (SPXs) and gymnodimines (GYMs) - in lipophilic extracts used for DSP toxin detection by mouse bioassay according to the modified Yasumoto method \[[@b12-md504168]\]. The presence of this group of compounds in shellfish was actually discovered because of the very high levels of acute toxicity induced in mice by i.p. injections of lipophilic extracts, causing rapid death in laboratory mice with neurotoxic symptoms (fast acting toxins, FAT). SPXs have been detected in shellfish in association with the dinoflagellate *Alexandrium ostenfeldii*, producing SPXs, firstly in North America \[[@b13-md504168]--[@b15-md504168]\] and then in Europe \[[@b16-md504168]--[@b18-md504168]\]. GYMs have been detected in shellfish in association with *Karenea selliformis* firstly in New Zealand \[[@b19-md504168],[@b20-md504168]\] and subsequently in Tunisia \[[@b21-md504168]\].

In France, among the toxic microalgae found along French coasts, three genera: *Dinophysis, Alexandrium* and *Pseudonitzschia*, have been specifically monitored \[[@b22-md504168]--[@b27-md504168]\]. When these algae are detected, the Phytoplankton and Phycotoxins Monitoring Network (REPHY) in charge of the French shellfish monitoring programme, performs toxicity analysis on exposed bivalves.

As regards lipophilic toxins, from the onset of a *Dinophysis* sp. outbreak, the REPHY proceeds with mouse bioassays for DSP toxin detection on a weekly basis throughout the risk period. The DSP mouse bioassay extraction protocol was initially optimised so as to adapt it for chemical analysis of mussel samples. Until 2003, the results of chemical analysis revealed the presence of OA and its derivative acyl-OA (DTX-3) in all samples, in proportions ranging from 50% to 100% of total OA-equivalent concentration \[[@b27-md504168]\]. During 2004--2005, for all shellfish samples found positive by mouse bioassay for DSP toxins, liquid chromatography (LC) coupled with mass spectrometry (MS) was used to search for the following lipophilic toxins: OA, DTXs, PTXs, AZAs, YTXs, SPXs and GYMs. In order to investigate the presence of acyl-OA and/or acyls-DTX-1,-2 (DTX-3), alkaline hydrolysis was performed on all samples, and LC-MS/MS analyses were carried out on these samples before and after hydrolysis. This paper reports on the first recorded occurrence of PTX-2,SPX-A and their isomers in French shellfish.

Materials and methods
=====================

Reference materials
-------------------

Certified reference materials provided by IMB-Halifax, NS, Canada: i) standard solutions of OA, PTX-2, SPX-desMeC and GYM-A; ii) homogenate of mussel (MUS-2) containing OA and DTX-1. Irish mussel samples containing AZAs (AZA-1,-2,3) and Italian mussel samples containing YTXs (YTX, Homo-YTX, 45-YTX, 45-homo-YTX) were used to investigate these toxins without quantification.

Shellfish samples
-----------------

During 2004-2005, several shellfish samples were collected at different production areas along the French coastline that had been previously closed due to the presence of lipophilic toxins. The shellfish samples were *Mytilus edulis galloprovincialis, Crassostrea gigas, Cerastoderma edule, Ruditapes decussates* and *Donax trunculus.* The samples had been collected by coastal laboratories in charge of the REPHY. For each type of sample, a minimum of 30 g of hepatopancreas (HP) was homogenized in a blender. Twenty g were used for the DSP mouse bioassay following the modified method of Yasumoto *et al.* \[[@b12-md504168]\]. The bioassay is regarded as positive if at least two out of three mice die within 24 hours. The remaining 10 g of HP homogenate were later used for LC-MS/MS analyses.

Extraction procedure for lipophilic toxins
------------------------------------------

[Figure 1](#f1-md504168){ref-type="fig"} shows the complete extraction procedure: lipophilic toxins were extracted from HP homogenate (2 g) according to the DSP mouse-assay protocol, already optimized with MUS-2 reference material. The resulting CH~2~Cl~2~ phase was then dried and diluted in MeOH. One aliquot was used for lipophilic toxins (except acyls-esters "DTX-3") analysis, and a second aliquot for DTX-3 alkaline hydrolysis to release OA, DTX-1, -2, and subsequent analysis of DTX3.

LC/MS-MS analyses of lipophilic toxins
--------------------------------------

For each shellfish sample, LC/MS-MS analyses were performed on two aliquots (before and after hydrolysis) in order to investigate lipophilic toxins as mentioned in [Figure 1](#f1-md504168){ref-type="fig"}. Each aliquot (5 μL) was injected into the LC/MS system using an Agilent 1100 LC model coupled to an API-2000 triple quadruple mass spectrometer equipped with a turboionspray source. LC-MS-MS analyses were performed by modifying the Quilliam method \[[@b28-md504168]\]. Toxins were separated in a BDS-Hypersil C8 column (50 mm x 2 mm id, 3 μm with a 10 mm guard cartridge) at 20°C. The mobile phase was 100% water containing 2 mM ammonium acetate and 50 mM formic acid (channel A) and acetonitrile/water (95/5) containing 2 mM ammonium acetate and 50 mM formic acid (channel B). The analyses were carried out using a linear gradient elution, starting with 30--95% B for 2.5 min, followed by an 8 min hold at 95% B and 5% A, and decreasing to 30% B over 0.5 min, which was held again for 5 min until the next run. The mobile phase flow-rate was set at 200 μL min^−1^. The instrument control, data processing and analysis were conducted using Analyst software.

The electrospray ionization interface (ESI) was operated in both positive and negative modes using the following parameters: curtain gas: 19; temperature: 400; gas 1: 30; gas 2: 50; CAD gas: 5; Ion spray voltage: 5000. These parameters had been previously optimized using toxin standards. The mass spectrometer was operated in multiple reaction-monitoring (MRM), analyzing the two or three most intense product ions per compound. For ESI positive, the transitions selected were: \[M+NH~4~\] ions: OA and DTX-2, m/z 822.5\>787.5/769.5/751.5; DTX-1, m/z 836.5\>818.5/800.5; PTX-2, m/z 876.5\>823.5/841.5/805.5; PTX-2-sa and 7-epi-PTX-2-sa, m/z 894.5\>841.5/805.5; \[M+H\] ions: SPX-A and SPX-desMeC, m/z 692.5\>674.5/444/164; GYM-A, m/z 508.5\>490.5/392.5, AZA-1, m/z 842.5\>824.5/806.5/672.5; AZA-2, m/z 856.5\>838.5/820.5; AZA-3, m/z 828.5\>810.5/792.5. For ESI negative mode, the transition selected was: \[M--H\] ions: YTX, m/z 1141.5 \>1061.5/855.5; HomoYTX, m/z 1155.5\>1075.5; 45-OH-YTX, m/z 1157.5\>1077; 45-OH-HomoYTX, m/z 1171.5\>1091.5.

Results and Discussion
======================

During a DSP outbreak associated with *Dinophysis* sp. that occurred in France between 2004 and 2006, shellfish samples tested positive to the mouse bioassay for lipophilic toxins. Our report presents the results of extensive analysis of these shellfish samples harvested from different locations: the Atlantic coast (Brittany, Arcachon Bay) and the Mediterranean coast (Thau lagoon, Corsica). The study was carried out using the comprehensive LC-MS-based approach which enabled us to investigate the presence of OA together with a wide range of lipophilic toxins distributed in European seas. [Figure 2](#f2-md504168){ref-type="fig"} shows a LC-SM/SM chromatogram of a calibration solution of available certified standards.

The primary finding was that all mouse-assayed shellfish samples contain OA and/or DTX-2 and their acyl-esters (DTX-3). DTX-1, YTXs, AZAs and GYMs toxins were not detected in all shellfish samples collected by REPHY.

[Table 1](#t1-md504168){ref-type="table"} shows the lipophilic toxin profiles and maximum amounts obtained from shellfish analysed in three areas during the 2005 monitoring programme: South Brittany, the Atlantic coast (Arcachon) and the Mediterranean coast (Thau lagoon). The toxicity profile varies as a function of the region: OA and acyl-OA were found in shellfish in all three regions, apart from in oysters, which contain only the acyl-OA. For mussels and clams the proportion of acyl-OA is quite large, varying between 61 and 94%. The DTX-2 is present in low concentrations in both forms (DTX-2, acyl-DTX-2) in clams harvested in South Brittany and in mussels from Arcachon. The proportion of acyl-DTX-2 varies from 26--40%. The presence of OA, of DTX-2 and their acyls-esters, was linked to the presence of *D. acuminata* and *D. acuta* in South Brittany, and *D. acuminata* on the Atlantic coastline (Arcachon). French shellfish have been contaminated by OA since 1983, and by DTX-2 since 2003 \[[@b24-md504168], [@b29-md504168]\].

The presence of PTX-2 and its derivatives were detected for the first time in France in 2004 in shellfish on the Mediterranean coast (Thau lagoon), and in 2005 in shellfish on the Atlantic coast (Arcachon) and South Brittany. Once accumulated in the shellfish flesh, smaller or larger proportions of the PTX-2 were subject to an enzymatic hydrolysis, manifesting in its transformation into PTX-2-seco acid (PTX-2-sa and 7-epi-PTX-2-sa) \[[@b30-md504168]\]. For all the French samples analysed, the proportion of PTX-2 in the PTX-2-sa form varies by between 55 and 95%, corroborating the research undertaken by Suzuki \[[@b31-md504168]\]. This contamination of shellfish by PTX-2 derivatives was linked to the presence of *D. acuta* and *D. acuminata*, which is known to produce PTX-2 \[[@b32-md504168]--[@b35-md504168]\]. [Figure 3](#f3-md504168){ref-type="fig"} shows various lipophilic toxin profiles of mussels from Atlantic and Mediterranean coasts analysed during the 2005 monitoring programme.

For Mediterranean shellfish samples (Thau lagoon) testing positive in the DSP bioassay, the concentrations of PTXs (PTX-2, PTX-2-sa and 7-epi-PTX-2-sa) were above the statutory thresholds (160 μg eq OA/Kg of shellfish tissue). [Figure 4](#f4-md504168){ref-type="fig"} shows an example of LC-SM/SM analysis of PTX-2 derivatives in a *C. gigas* sample taken from Mediterranean coast.

For shellfish samples taken from Arcachon Bay (Atlantic coast), neurological symptoms and rapid deaths (in from 5 to 15 minutes) were observed in mice with shellfish samples tested according to the DSP bioassay. Neurotoxic effects on mice were due to the presence of SPXs (SPX-A, SPX-desMeC) detected for the first time in French shellfish in April 2005 ([Figure 5](#f5-md504168){ref-type="fig"}).

The concentration of SPXs, associated with the presence of *A. ostenfeldii* cells in sea water, was close to 60 μg/kg of shellfish tissue. In addition to SPXs, other DSP toxins were detected (OA, DTX-3, PTX-2, PTX-2-sa, 7-epi-PTX-2-sa), at levels well below the statutory thresholds, in association with the presence of *D. accuminata.* Lack of a European regulatory limit for SPXs and other appropriate toxicological data resulted in the shellfish areas in the bay of Arcachon being closed for 10 weeks as a precautionary measure.

This first observation has been followed up by other sightings of SPXs in trace quantities at other points along the French coastline, and particularly in South Brittany. On the international plane, SPXs are not regulated because we do not yet dispose of objective tools for assessing their toxicity for humans, in part because these toxins have been identified in the framework of shellfish monitoring programmes, rather than as a follow-up to human intoxication, notably in Canada \[[@b14-md504168],[@b15-md504168]\] and in Norway \[[@b16-md504168]\].

Conclusions
===========

Our results have revealed different lipophilic toxin profiles depending on the shellfish sampling location. The primary finding was that all of the samples contained OA and acyl-OA. In addition to these toxins, different lipophilic toxins were found depending on the shellfish area: i) DTX-2 and acyl-DTX-2 in southern Brittany; ii) PTX-2 derivatives along the Mediterranean coast (Thau lagoon, Corsica); iii) PTX-2, SPX-A and their derivatives on the Atlantic coast (Arcachon Bay). This study reports on the first occurrence of PTX-2, SPXs and associated derivatives in French shellfish. As regards SPXs, conclusive toxicological studies are required to elucidate the public health relevance of the different SPXs derivatives, and to provide a scientific basis for establishing regulatory control.
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![Lipophilic toxin profiles for different shellfish locations analysed during the 2005 monitoring programme](md-5-168-g003){#f3-md504168}

![Example of LC-MS/MS analysis of PTX-2 derivatives in *Crassostrea gigas* from the Mediterranean coast.](md-5-168-g004){#f4-md504168}

![Example of LC-MS/MS analysis of lipophylic toxins in shellfish from the Bay of Arcachon.](md-5-168-g005){#f5-md504168}

###### 

Maximum amount of toxins in μg /Kg of whole tissue found during the 2005 monitoring programme.

                      South Brittany                               Atlantic coast (Arcachon bay)                Mediterranean coast (Thau Lagoon)                                                                                                      
  ------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  OA                  37                                           86                                           DL[a](#tfn1-md504168){ref-type="table-fn"}   199                                          DL[a](#tfn1-md504168){ref-type="table-fn"}   131
  Acyl-AO (DTX3)      554                                          231                                          180                                          585                                          46                                           83
  DTX2                26                                           DL[a](#tfn1-md504168){ref-type="table-fn"}   DL[a](#tfn1-md504168){ref-type="table-fn"}   5                                            DL[a](#tfn1-md504168){ref-type="table-fn"}   DL[a](#tfn1-md504168){ref-type="table-fn"}
  Acyl-DTX-2 (DTX3)   17                                           DL[a](#tfn1-md504168){ref-type="table-fn"}   DL[a](#tfn1-md504168){ref-type="table-fn"}   2                                            DL[a](#tfn1-md504168){ref-type="table-fn"}   DL[a](#tfn1-md504168){ref-type="table-fn"}
  PTX2                2                                            DL[b](#tfn2-md504168){ref-type="table-fn"}   5                                            36                                           22                                           26
  PTX2-sa             22                                           DL[b](#tfn2-md504168){ref-type="table-fn"}   4                                            261                                          170                                          126
  7-epi-PTX2-sa       16                                           DL[b](#tfn2-md504168){ref-type="table-fn"}   2                                            94                                           33                                           116
  SPX-desMeC          8                                            14                                           47                                           19                                           DL[c](#tfn3-md504168){ref-type="table-fn"}   DL[c](#tfn3-md504168){ref-type="table-fn"}
  SPX-A               DL[c](#tfn3-md504168){ref-type="table-fn"}   7                                            DL[c](#tfn3-md504168){ref-type="table-fn"}   68                                           DL[c](#tfn3-md504168){ref-type="table-fn"}   DL[c](#tfn3-md504168){ref-type="table-fn"}
  SPX-desMeD          2                                            2                                            DL[c](#tfn3-md504168){ref-type="table-fn"}   DL[c](#tfn3-md504168){ref-type="table-fn"}   DL[c](#tfn3-md504168){ref-type="table-fn"}   DL[c](#tfn3-md504168){ref-type="table-fn"}

detection limit of AO group: 5 μg/kg of whole tissue.

detection limit of PTX-2 group: 4 μg/kg of whole tissue.

detection limit of SPX-desMeC group: 1 μg/kg of whole tissue.
